Hexarelin Peptide For Sale
Buy Hexarelin peptide: 2mg or 5mg listed purchase quantities. Compare live prices across 2 listed vendors with real cost per mg, recorded COA availability and discount codes.
Buy Hexarelin peptide starting at $19.40/purchase from 2 listed vendors. Compare 2mg and 5mg purchase quantity options by cost per mg, price per purchase, monthly cost, discount codes and recorded COA metadata (not independent verification).
About Hexarelin
In clinical trialsHexarelin is a synthetic hexapeptide growth-hormone secretagogue (a close GHRP-6 analogue) sourced for GH-release and cardiovascular research. It ships as a lyophilized powder you reconstitute before use, so vendor quality comes down to what the certificate of analysis (COA) shows.
What to check before you buy Hexarelin:
- A third-party COA showing ≥98% purity by HPLC plus mass-spec confirmation of the hexapeptide sequence (including its 2-methyl-Trp modification) — not just an in-house "tested" stamp.
- A COA dated within the last 6–12 months that matches the exact vial size and batch you are buying.
- Accurate vial fill: a labeled 5mg vial should assay close to 5mg. Under-filled or mislabeled vials are a common failure mode and throw off your dose math.
No regulatory approvals anywhere in the world. Investigated in Phase 1/2 trials for short stature and GH-deficiency diagnostic testing in the 1990s; later studied pre-clinically and in small mechanistic human studies for cardioprotection via the CD36 receptor.[3][4] **Typical dose:** Historical clinical use: 1–2 µg/kg subcutaneous or intravenous for GH-stimulation testing; up to 60 µg/kg for chronic studies of GH responsiveness in children with short stature. Chronic administration in healthy adults produces rapid receptor desensitisation, with the GH response largely attenuated within 4–16 weeks of daily dosing — a well-documented limitation of the molecule.[2][5]
Regulatory: Reached Phase 1/2 for GH-deficiency diagnostic testing in the 1990s; not approved. WADA-prohibited.
Hexarelin: Mechanisms, Half-Life & Research Data
A skimmable deep dive into how Hexarelin works and what it is being studied for — tied back to what size to buy. Detailed debates and community notes are tucked into the expandable panels below. All citations resolve to the sources list at the bottom of this page.
How it works
Hexarelin was developed at Mediolanum Farmaceutici (Milan) as a follow-on to the original Bowers-group GH-releasing peptides (GHRP-6, GHRP-2). The first-in-human pharmacology was published in 1994 by Imbimbo and colleagues, with the more detailed dose-response and acute safety characterisation appearing the same year from the Ezio Ghigo group in Turin.[1][2] Hexarelin acutely produces a pulse of GH release roughly comparable to GHRH on a µg-for-µg basis, and synergistic with GHRH when the two are co-administered. Clinical interest as a GH-replacement strategy faded by the late 1990s for two reasons: rapid down-regulation of the GH response on chronic dosing,[5] and the parallel rise of recombinant human GH as a safer and better-characterised replacement therapy. A second wave of academic interest followed Bodart et al.'s identification in 2002 of CD36, not GHS-R1a, as the receptor mediating Hexarelin's cardioprotective effects in isolated heart and post-MI animal models.[3] At GHS-R1a, Hexarelin acts as a mimetic of the endogenous ligand ghrelin and produces the canonical Gαq/PLC/IP3-Ca²⁺ pulse in somatotrophs. Its in-vivo GH-releasing potency exceeds GHRP-6 because of the 2-methyl-Trp modification, which increases receptor affinity and resistance to enzymatic degradation. At CD36 — a fatty-acid translocase / class-B scavenger receptor expressed on cardiomyocytes and endothelium — Hexarelin produces a cardioprotective phenotype in pre-clinical ischemia-reperfusion models, with reductions in infarct size and apoptosis that are preserved in hypophysectomised animals (i.e. independent of GH and IGF-1).[3][4] The dual-receptor mechanism is the reason Hexarelin behaves as a "non-classical" GHS in chronic dosing experiments — the cardiovascular signal persists when the pituitary GH response has been desensitised.
Active research areas
- Research status & evidence base**Human evidence (GH-axis):** moderate. Acute and short-duration dose-response studies in healthy adults, GH-deficient children, and adults with various forms of pituitary disease established the GH-releasing pharmacology and the synergy with GHRH in the mid-1990s.[1][2] Chronic-dosing studies showed that the GH response down-regulates within weeks of daily administration, which is the principal reason Hexarelin did not advance as a GH-replacement therapy.[5] **Human evidence (cardiovascular):** limited. Small mechanistic studies (e.g. acute haemodynamic and left-ventricular function studies in patients with GH deficiency or chronic heart failure) have been published, but no large outcome trial.[4] **Pre-clinical evidence (cardiovascular):** the CD36-mediated cardioprotection is well-replicated in rat and mouse ischemia-reperfusion and post-MI models.[3][4] **Anti-doping context:** Hexarelin is on the WADA Prohibited List year-round (S2 peptide hormones, GH-releasing peptides), and standard sports-doping labs include it in their GHS panel.[5]
Open questions & leading hypotheses (2)
- Hypothesis: Chronic Hexarelin produces useful sustained GH/IGF-1 elevation in healthy adults.Evidence: Counter-evidence is strong: published chronic-dosing studies in healthy adults and short-stature children show the GH response largely attenuates within 4–16 weeks of daily dosing,[5] which is the historical reason Hexarelin and the GHRP class did not advance as GH-replacement therapies.
- Hypothesis: CD36-mediated cardioprotection translates to a useful clinical benefit in humans with ischemic heart disease or heart failure.Evidence: Supported by pre-clinical infarct-size and apoptosis data,[3] and by small mechanistic human studies of acute haemodynamics.[4] Counter-evidence: no outcome trial has been conducted; cardioprotection in animal MI models has been notoriously poor at translating to clinical mortality benefit across many drug classes.
What community users report
Anecdotal — not controlled-trial evidence
Hexarelin is discussed on r/Peptides and r/Steroids as a high-potency GH secretagogue typically used in short ~4-week pulses (50–200 µg subcutaneous 1–3×/day) specifically to avoid the desensitisation that limits longer protocols. Users frequently report appetite increase (a ghrelin-receptor effect) and acute cortisol/prolactin elevation. **Hexarelin is on the WADA Prohibited List year-round and is detectable on standard GHRP screens; no FDA-registered manufacturer makes it; the GH response is well-documented to down-regulate within weeks of daily dosing; and there is no human outcome-trial evidence for the cardioprotective indication.** Anecdotal benefit reports should be read against that evidence base and the desensitisation pharmacology.
Sources & references (5)
Peer-reviewed literature, FDA documents, and trial registrations cited above. Vendor pricing, COA data, and live calculator statistics shown elsewhere on this page are sourced from the WPA database independently of this list.
- [1]Ghigo et al., J Clin Endocrinol Metab 1994 (PMID: 8077305) — Hexarelin pharmacology in healthy adults link
- [2]Imbimbo et al., Eur J Clin Pharmacol 1994 (PMID: 8001022) — first-in-human Hexarelin study link
- [3]Bodart et al., Endocrinology 2002 (PMID: 11861509) — CD36 as the cardiovascular receptor for Hexarelin link
- [4]Broglio et al., Eur J Endocrinol 2002 (PMID: 12270939) — cardiovascular effects of Hexarelin independent of GH link
- [5]Rahim, O'Neill & Shalet, Clin Endocrinol 1998 (PMID: 9876342) — desensitisation of GH response to chronic GHRP link
What Hexarelin Costs Right Now
WPA currently tracks Hexarelin from 2 distinct vendors. In-stock Hexarelin vials run from $19.40 to $64.60 — a 3.3x spread for the same compound. Swiss Chems holds the lowest sticker price at $19.40. Normalized to milligrams, Hexarelin costs $9.70/mg to $12.92/mg on this page. The best per-milligram value is the listed 2 mg purchase quantity from Swiss Chems.
Hexarelin is stocked in 2 sizes: 2 mg listed quantity; vial count not recorded; 5 mg listed quantity; vial count not recorded. Because vials of different strengths rarely scale linearly in price, the per-milligram column is the only fair way to rank them.
Ranked by true cost per milligram, the Hexarelin listings WPA tracks are: Swiss Chems — 2mg at $19.40 ($9.70/mg); Paramount Peptides — 5mg at $64.60 ($12.92/mg), COA purity 99.40%.
Hexarelin COA Coverage Across Tracked Vendors
1 of the 2 tracked Hexarelin listings (50%) are marked as having COA availability in WPA's listing data; this marker is not independent verification. A purity value is recorded for 1 listing; purity alone does not establish identity or independent testing. The recorded purity value is 99.40%. 1 listing records more Hexarelin in the vial than the label claims; check the vendor's report and batch before drawing conclusions. The latest COA date recorded in WPA's listing data is 3/26.
To assess a COA, inspect the actual report for the independent lab, test date, and a batch and vial size matching the Hexarelin offer. WPA's listing fields do not establish that a report was independently verified.
Hexarelin Calculator Input Observations
In lifetime Hexarelin calculator inputs, 200mcg is the most frequent entered amount (5 of 14 runs). Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length. As nominal quantity arithmetic only, 5 mg of listed product divided by 0.2 mg gives roughly 25 portions before preparation losses. This does not establish vial count, stability after preparation, or cycle length.
Hexarelin Discount Codes
2 of the 2 tracked Hexarelin listings carry a WPA researcher discount code. The largest live discount is 10% off. Every price and per-milligram figure on this page is the post-discount number, so you are never comparing a discounted listing against an undiscounted one. Codes change and some exclude sale items or carry order minimums.
About Hexarelin
Hexarelin is a synthetic hexapeptide growth-hormone secretagogue (a close GHRP-6 analogue) sourced for GH-release and cardiovascular research. It ships as a lyophilized powder you reconstitute before use, so vendor quality comes down to what the certificate of analysis (COA) shows.
Hexarelin is tracked under the Muscle Peptides category on WPA. Its reported half-life is ~55 min. Calculator inputs do not establish why a cadence was selected or validate a protocol. Reached Phase 1/2 for GH-deficiency diagnostic testing in the 1990s; not approved.
How to Read the Hexarelin Comparison
- Price per milligram — Every Hexarelin listing is normalized to $9.70/mg-style unit pricing, so a small cheap vial cannot hide a worse real cost than a larger one.
- COA metadata and purity — 1 Hexarelin listing is marked for COA availability, and 1 has a recorded purity value. These fields do not independently verify a report.
- Vials sizes — The Hexarelin comparison includes 2mg and 5mg listed purchase quantities. Check package composition separately.
- Stock status — Live in-stock state for each Hexarelin listing, refreshed on a recurring basis.
Frequently Asked Questions: Hexarelin
Is it legal and safe to buy Hexarelin for research?
In the US, Hexarelin is sold strictly as a research chemical — legal to buy for laboratory research but not approved for human use. It is a growth-hormone-releasing peptide (GHRP) with no approved human use, sold strictly for laboratory research. The real variable isn't legality, it's quality: unverified suppliers can ship underdosed, impure, or mislabeled material. WPA records COA-related listing fields where supplied, but does not independently verify every report. Inspect the actual batch report and its laboratory, identity testing, and date before drawing conclusions. Right now that screen covers 2 Hexarelin listings from 2 vendors.
How do I verify a Hexarelin COA so I'm not getting an underdosed vial?
A Certificate of Analysis (COA) may report tests for a specific Hexarelin batch. Check that the report identifies the compound (actually hexarelin, not a cheaper GHRP-2 or GHRP-6 substitute), names the laboratory, describes the test method and result, and matches the offered batch and date. A recorded purity value or COA-availability flag in WPA's listing data is not independent verification. Open the vendor listing and inspect the actual report before drawing conclusions. For Hexarelin specifically, 1 of 2 tracked listings (50%) are marked as having COA availability in WPA's listing data; that marker is not independent verification. A purity value is separately recorded for 1 listing; purity alone does not establish identity or independent testing. The latest COA date recorded in the listing data is 3/26.
Which Hexarelin vendor should I pick?
There's no single "best" Hexarelin vendor — it depends on what you weigh most. WPA ranks tracked listings using recorded purity and date fields where available, visitor click activity, price, stock status, and discount data; this ranking is not independent verification of a report. Hexarelin is easy to swap for the cheaper GHRP-2 or GHRP-6, so favor vendors whose COA confirms the hexarelin sequence. 2 vendors currently carry Hexarelin, and Swiss Chems holds the best true value at $9.70/mg on the 2 mg listed purchase quantity. Review the actual report and confirm its batch details before making a decision.
How much does Hexarelin cost — and how do I know I'm not overpaying?
Judge Hexarelin by true price per milligram, not the sticker price on one vial — a cheap small vial often costs more per mg than a larger one. It most often ships in 2 mg and 5 mg vials, so compare $/mg across those — the 5 mg vial usually wins on price per mg. Tracked Hexarelin listings currently run $9.70/mg to $12.92/mg across 2mg, 5mg listed purchase quantities (not necessarily single vials). WPA normalizes tracked listings to $/mg, and the live cost-per-month card estimates your spend at the most common dose. The one catch: the lowest $/mg sometimes means buying a bigger vial than your cycle needs.
How much Hexarelin do I need for one full cycle?
In lifetime Hexarelin calculator inputs, 200mcg is the most frequent entered amount (5 of 14 runs). Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length. Dividing the listed 5 mg purchase quantity by 0.2 mg gives roughly 25 nominal portions before preparation losses; vial count and stability after preparation are separate questions. A cycle requires an independently chosen amount, cadence and time horizon; calculator observations do not supply those decisions. Compare nominal package quantities and model your own selections in the cost card.
Are discount codes available for Hexarelin?
Participating Hexarelin vendors may offer WPA researcher discount codes. Codes can change, exclude sale items or carry order minimums. 2 of the 2 tracked Hexarelin listings carry a code right now, the largest worth 10% off. Each listing shows the recorded code and discounted price where available; confirm the actual package and checkout terms with the vendor.
Where can I compare Hexarelin prices and listing details?
This comparison shows 2 tracked listings for Hexarelin in the selected format. Compare purchase price, established nominal quantities, discount terms and recorded COA availability, purity and date fields. Those fields are not independent verification. Inspect actual batch reports and confirm package composition and checkout price on the vendor's site.